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ABSTRACT
The TREX enzymes process DNA as the major 3’!5’
exonuclease activity in mammalian cells. TREX2 and
TREX1 are members of the DnaQ family of exonu-
cleases and utilize a two metal ion catalytic mech-
anism of hydrolysis. The structure of the dimeric
TREX2 enzyme in complex with single-stranded
DNA has revealed binding properties that are dis-
tinct from the TREX1 protein. The TREX2 protein
undergoes a conformational change in the active
site upon DNA binding including ordering of active
site residues and a shift of an active site helix.
Surprisingly, even when a single monomer binds
DNA, both monomers in the dimer undergo the
structural rearrangement. From this we have pro-
posed a model for DNA binding and 3’ hydrolysis
for the TREX2 dimer. The structure also shows
how TREX proteins potentially interact with
double-stranded DNA and suggest features that
might be involved in strand denaturation to provide
a single-stranded substrate for the active site.
INTRODUCTION
The 30!50 exonucleases provide an essential function in
a variety of DNA metabolic pathways. Traditionally
thought of as primarily processing 30-termini for DNA
replication, repair and recombination events, our under-
standing of their roles has grown to include other meta-
bolic pathways, such as degrading single-stranded DNA
(ssDNA) to prevent autoimmune dysfunction (1–4). The
TREX2 and homologous TREX1 enzymes provide the
major 30-exonuclease activity observed in mammalian
cell extracts (5–7). Recently, mutations in the TREX1
gene have been identiﬁed as the underlying cause of the
neurological brain disease, Aicardi–Goutieres syndrome
and familial chilblain lupus, both diseases having pathol-
ogies related to an aberrant immune response character-
ized by symptoms that include induction of type I
interferons and circulating auto-antibodies reactive
to single-stranded and double-stranded DNA (dsDNA).
One function of TREX1 is to degrade ssDNA derived
from processing of aberrant replication intermediates or
from endogenous retroelements to prevent their accumu-
lation and activation of cell-intrinsic antiviral defense
(4,8). The TREX1 protein has also been identiﬁed as
the granzyme-A activated exonuclease within the SET
complex, an endoplasmic reticulum (ER)-associated com-
plex that contains the SET protein, the endonuclease,
NM23-H1 and the base excision repair exonuclease,
Ape1 as well as several other proteins (1). The interaction
with this complex is speciﬁc for the TREX1 protein and
not TREX2 (1), leaving the cellular role of TREX2 unde-
ﬁned and suggesting diﬀering biological functions for
these two enzymes.
The TREX1 and TREX2 enzymes are Mg
2+ ion-
dependent deoxyribonucleases belonging to the DnaQ-
like exonuclease family. The DnaQ family has been
divided into two subfamilies characterized by the presence
of four conserved carboxylate residues and a histidine
(DEDD-h) or a tyrosine (DEDD-y) positioned in the
active site. The side chains of the four conserved carbox-
ylate residues in TREX1 and TREX2 coordinate two
Mg
2+ ions and the histidine is positioned to deprotonate
a water producing a nucleophile to attack the target phos-
phodiester bond and eﬀect hydrolysis. The TREX1 and
TREX2 enzymes are the only known mammalian deoxy-
ribonuclease members of the DEDD-h subfamily and
prefer excision of deoxynucleotide substrates over ribonu-
cleotides by about 1000-fold (6). The TREX1 and TREX2
proteins share about 40% sequence identity and not sur-
prisingly similar overall 3D structures (9–11). However,
distinct diﬀerences between the proteins support the
idea of independent cellular functions for these two exo-
nucleases. The TREX1 protein contains an extended
C-terminal domain of about 76 amino acids not present
in TREX2 that plays a putative role in anchoring TREX1
to the cytosolic side of the ER membrane (12). The
TREX1 protein also contains a non-repetitive proline-
rich region not present in TREX2 that is thought to
play a speciﬁc role in protein–protein interactions, such
as that with the SET complex (9,10). Additionally, kinetic
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lower eﬃciency for TREX2 relative to that of TREX1
(6,11,13,14).
Our previous characterization of the TREX2 protein
revealed a mobile loop adjacent to the active site provides
themajorDNA binding element andcontributesto thecat-
alytic eﬃciency of the enzyme (11,15). Mutations of three
arginine residues within this loop of TREX2 resulted in a
60-fold decrease exonuclease activity; a result of increased
KM with no eﬀect on kcat. We have also shown evidence
for cooperative DNA binding with the TREX2 protein and
coordinatedcatalysisbetweentheprotomersoftheTREX2
dimer (15). Heterodimers of TREX2 containing one wild-
type protomer and one catalytically inactive protomer
(TREX2
wt/H188A) showed a 7-fold decrease in catalytic
activity in contrast to a 2-fold lower activity in the DNA
binding heterodimer (TREX2
wt/R163A-R165A-R167A). The
decrease in the TREX2
wt/H188A heterodimer indicates
that the defective catalysis in one protomer reduces the
activity in the opposing protomer.
In order to understand the structural aspects of the
TREX2 protein that contribute to the coordinated catal-
ysis and identify a possible mechanism for communication
between the active sites, we determined the crystal struc-
ture of the TREX2 dimer in complex with ssDNA and
Ca
2+. The structure revealed several novel aspects of
TREX2–DNA interaction including a conformational
change in the active site upon binding that is communi-
cated across the dimer interface, as well as a sequential
mode of binding DNA and divalent metal ion.
Additionally, we have identiﬁed a structural motif that
may contribute to displacement of dsDNA to provide
single-stranded substrate to the active site.
MATERIALS AND METHODS
Proteinexpression, purification and crystallization
The human TREX2 protein was expressed and puriﬁed as
previously described (10,11,16). The protein–nucleic acid
complexes were crystallized by the hanging drop vapor
diﬀusion technique using TREX2–DNA complex formed
by mixing protein with a ssDNA oligonucleotide (GACG)
in a molar ratio of 1:2 in the presence of 2mM CaCl2.
Two microlitres of protein complex at 5mg/ml was mixed
with equal volume of reservoir solution and suspended on
a cover slip above the 200ml reservoir. The TREX2–DNA
complex crystallized using 4.5% PEG 4000, 5% 2-methyl-
2,4-pentanediol (MPD), 50 mM HEPES pH 7.2, 200mM
NaCl and 2mM CaCl2. Crystallization experiments were
carried out at 208C and crystals appeared within 1 week.
X-raydatacollection, phasing andrefinement
Prior to data collection crystals were soaked in reservoir
solution containing 6% PEG 4000, 7% MPD, 50mM
HEPES, pH 7.2, 200mM NaCl and 2mM CaCl2 for 3–5
days. Crystals were then mounted in a nylon loop and
ﬂash frozen in liquid nitrogen. X-ray data were collected
using Cu Ka radiation on a MicroMax 007 generator and
a Saturn 92 CCD detector (Rigaku). Intensity data were
processed with the program d
 TREK (17). Crystals of the
TREX2–DNA complex belong to space group P21 with
unit cell dimensions a=55.5 A ˚ , b=78.1A ˚ , c=162.9A ˚ ,
a=g=908, b=90.68 (Table 1).
Phases for the data were obtained by molecular replace-
ment using the program PHASER (18) and a monomer of
the hTREX2 apo protein (pdbid: 1Y97) (11) as a search
model. The TREX2–ssDNA–Ca
2+ model was built using
the program COOT (19). The structure was reﬁned with-
out restraints of non-crystallographic symmetry (NCS)
using the programs CNS and Refmac5 (20,21), and the
validity of the reﬁned structure conﬁrmed by simulated
annealing-omit procedures (20). The change in the free
R-factor was monitored at each step in reﬁnement, as
well as the inspection of stereochemical parameters with
the programs Molprobity (22) and ERRAT (23). The
model of the complex converged with a ﬁnal R-factor
of 25.5% (Rfree=30.0%) using all observed X-ray
data measurements in the resolution range 20–3.0A ˚ .
A Ramachandran plot shows that >90% of all residues
in the models have  and c angles in the most preferred
regions. All ﬁgures of molecular structures were created
using the program PyMOL. Atomic coordinates for the
TREX2–ssDNA–Ca
2+ complex have been deposited in
the Protein Data Bank.
RESULTS AND DISCUSSION
Structure ofTREX2–DNA complex
We crystallized the human TREX2 protein in complex
with ssDNA and Ca
2+. The structure was determined
by molecular replacement using the unliganded TREX2
protein as a search model (Table 1). The correct solution
provided an initial R-factor of about 46% after a round
of rigid body reﬁnement. The asymmetric unit of the
crystals contains three dimers of the TREX2 protein.
Table 1. Crystallographic data and reﬁnement statistics
Complex TREX2/ssDNA
Space group P21
Unit cell (A ˚ ) a=55.51, b=78.08, c=162.88;
 =908, b=90.68, g=908
Molecules (a.u.) 6
Wavelength (A ˚ ) 1.54
Resolution (A ˚ ) 20–3.1
Completeness (%) 94.4 (92.4)
Rmerge (%)
a 14.5 (36.1)
Mean (I/s) 3.3 (2.1)




Average B-factor protein (A ˚ 2) 34.5
Average B-factor nucleotide (A ˚ 2) 44.6
Average B-factor water (A ˚ 2) 19.4
RMSD bond lengths (A ˚ ) 0.015
RMSD bond angles (degree) 2.92
aRmerge=R|I <I>|/RI, where I is the observed intensity and <I> is
the average intensity.
bR-factor=R||FO| |FC||/R|FO|. Rfree is the same as R, but calculated
with 10% of the reﬂections that were never used in crystallographic
reﬁnement.
Statistics for outer resolution shell are given in parentheses (3.1–3.2A ˚ ).
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dimers has DNA bound in both active sites while the
other two have DNA bound in only a single active site,
indicating a sequential binding mechanism for TREX2
(Figure 1). A superposition of a TREX2 monomer
with bound DNA onto each of the holo monomers in
the asymmetric unit conﬁrms that there is room to
accommodate the oligonucleotide and that the lack of
binding is not due to crystal packing or other steric hin-
drances. The details of the dimeric nature of the TREX2
protein in the absence of DNA have been described pre-
viously (11) and are similar to our current structure with
the exceptions described below.
The ssDNA is bound in the TREX2 active site through
a combination of sequence-independent hydrogen bond-
ing and hydrophobic interactions (Figure 1). A single
Ca
2+ ion is observed in the active site, coordinated by
the conserved acidic residues and scissile phosphate oxy-
gens. The metal ion occupies the canonical position B,
leaving position A unoccupied [for a review see (24)].
Similar to the TREX1–DNA complex (10), the terminal
nucleotide is anchored in the active site by hydrogen
bonds between the 30-hydroxyl and a carboxylate oxygen
of Glu16 as well as the backbone amide nitrogen of Ala17.
The nucleotide base is stabilized in a hydrophobic pocket
between Leu20 and the hydrophobic face of helix a2. The
phosphodiester backbone of the 4nt are held to the pro-
tein through the interaction of Arg152 and hydrogen
bonds with the backbone amide nitrogens of the distal
end of the a6-a7 loop (amino acids 170–172). Unlike the
TREX1–DNA complex in which Arg128 is twisting
the base of the 50-nucleotide into a syn conformation,
the equivalent residue, Asp121, in TREX2 is unable to
carry out a similar interaction, leaving the nucleotide in
the anti conformation.
We have previously shown that the TREX2 exonuclease
cooperatively binds DNA and that there is an interdepen-
dence of activity in the dimer (15). Catalytic inactivation
of one of the monomers (TREX2
H188A/TREX2
wt) in the
dimer showed a 7-fold decrease in exonuclease activity,
indicating communication across the dimer interface. It
would be expected that if each of the monomers within
the dimer operated independently, inactivation of a single
monomer would produce only a 2-fold decrease in activ-
ity. By comparing our current structure of the TREX2
protein in two DNA binding modes with the existing
structure of TREX2 in the apo form (11), we observe
conformational rearrangement of residues localized
around the active site that help explain the interdepen-
dence of activity between the monomers (Figure 2).
A superposition of the TREX2 dimer in the unbound
form, with either the single DNA bound and double
DNA bound form has an RMSD of 0.95 or 0.96A ˚ ,
respectively (calculated using Ca atoms). In the absence
of bound DNA and divalent ions two speciﬁc regions of
the protein are disordered—residues 158–169, comprising
the arginine-rich DNA binding loop, and residues 185–188
that contain the catalytic residue His188 (11). When the
DNA binding loop of one monomer of the TREX2 dimer
interacts with DNA to position it in the active site, we see
an ordering of residues 165–169 as well as residues
185–188. Further ordering of amino acids 158–164 may
happen in the presence of longer oligonucleotide sub-
strates. What is most notable about these structures is
that even with a single oligonucleotide binding the dimer
ordering of these residues takes place in both monomers.
We also observe a 1.8A ˚ shift of helix a7 towards the active
site, better positioning the d
+ dipole moment of the helix
to contribute to DNA stabilization (Figure 2). The shift of
the a7 helix also moves the amide nitrogen of Tyr170 and
Leu172 in the preceding loop to within hydrogen bond
distance of the DNA phosphate groups. Previous kinetic
studies of TREX2 have demonstrated the catalytic role of
His188, and presumably ordering of the loop containing
H188 is required for eﬃcient nucleotide hydrolysis (11).
Together, the result of these conformational changes
appears to provide a signiﬁcant increase in DNA interac-
tions that likely enhance substrate binding.
Based on these observations, we can propose a model
for TREX2–DNA binding and activity in which the
monomers function in a cooperative and synergistic fash-
ion with each other (Figure 3). First, when DNA is
engaged by the arginine-rich binding loop of either mono-
mer in the dimer a conformational change is induced that
Figure 1. TREX2 DNA binding. The crystals of the TREX2–DNA
complex have three dimers in the asymmetric unit. One of the dimers
has ssDNA bound in both active sites while the other two dimers have
ssDNA bound in only one of the active sites. (A) Fo-Fc annealed omit
diﬀerence electron density (1 s) showing ssDNA density in one of the
active sites. Calcium ion shown in magenta. (B) Schematic showing the
relative positioning of the three TREX2 dimers in the asymmetric unit.
The bound ssDNA is represented by red lines.
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the active site of that monomer. This is consistent with
the biochemical data that show TREX2 cooperatively
binds DNA and the cooperativity exists within each
monomer (15). The conformational change due to DNA
binding in one monomer is then structurally transmitted
to the opposing monomer which also adopts the same
conformation and may now also have a higher aﬃnity
Figure 2. TREX2 active site conformational change upon DNA binding. A comparison of the TREX2 structures with (A) no DNA bound, (B) one
ssDNA oligonucleotide bound to one active site in the dimer and (C) ssDNA bound to both active sites in the dimer. Binding of ssDNA to one
monomer induces a conformational change in the active site of both monomers (aﬀected residues shown in red). This includes ordering of DNA
binding residues and residues 185–188, which contains the catalytic H188 (shown in gold circle). (D) A superposition of TREX2 bound to DNA
(blue) onto the apo TREX2 structure (gold) shows there is also a shift of helix a7 in both monomers that brings the helix closer to the DNA and
allows the backbone amide nitrogens of residues 170 and 172 move within hydrogen bonding distance. (E) Superposition of TREX2 dimers in apo
(gold), single (green) and double DNA bound (blue) states. The single and double bound states have an RMSD of 0.95 and 0.96A ˚ , respectively, with
the unbound protein. The structures are extremely similar in the dimer interface region with the major structural shifts occurring at the active sites.
Figure 3. Model for TREX2 DNA binding. (A) Substrate DNA is recognized by arginine-rich DNA binding loop. (B) The loop positions the 30-end
of the substrate into the active site (yellow rectangle). (C) Presence of ssDNA in the active site induces a conformational change in the active site
(yellow oval) of both monomers. (D) Both monomers now have a higher aﬃnity for DNA and increased catalytic eﬃciency.
2414 Nucleic Acids Research, 2009, Vol. 37,No. 7for substrate. In other words, binding of a DNA
30-terminus in the active site by one monomer increases
substrate aﬃnity of both the monomers. If indeed
the ordering of an opposing active site allows increased
30-terminus binding and higher catalytic eﬃciency, this
model would then imply that DNA binding in the active
site is the rate limiting step in catalysis, which is also con-
sistent with previous kinetic measurements (15).
The greater than 2-fold loss in activity observed upon
mutation of the catalytic His188 to alanine within the
mutant/wild-type heterodimer suggests that this residue
participates in the apparent communication of activity
between the monomers of the TREX2 dimer. It also sug-
gests that the 185–188 loop plays a role in the increased
aﬃnity for the 30-terminus, and if the loop fails to become
ordered in one monomer then the conformational change
in the active site is not transmitted to the opposing mono-
mer. The second monomer would then function without
the beneﬁt of increased binding or eﬃciency, and there-
fore, at less than half of maximal measured capacity. It
is possible that ordering of the 185–188 loop is dependent
upon both DNA binding and the side chain of the histi-
dine making interactions in the active site. Previous struc-
tural studies of the DEDD-h exonucleases show the
conserved histidine side chain making interactions with
the nucleophilic water molecule coordinated by the
DNA and divalent metal ion in the substrate complexes,
as well as with a phosphate oxygen in the product com-
plexes (10,25).
The mode of TREX2–DNA binding in our current
structure is a contrast to the structure of the TREX1–
DNA complex that showed a saturation of the active
sites with substrate when crystallized with an equivalent
ratio of ssDNA (9,10). There also did not appear to be
active site conformational changes within the TREX1
structure upon binding substrate (9,10). These structural
diﬀerences suggest diﬀerences in mechanism between
the two proteins. If the TREX1 active site does not
undergo conformational changes upon substrate binding
as TREX2 appears to do there would be less of an entro-
pic barrier for hydrolysis. This is consistent with the fact
that the TREX1 enzyme is about 10-fold more eﬃcient
than the TREX2 protein (14). Additionally, the individual
monomers of the TREX1 dimer appear to have equal
aﬃnity for DNA. In contrast, the conformational
change induced in both active sites of the TREX2 dimer
by binding of DNA to one of the active sites indicates
there may be an increased aﬃnity for DNA in the
unbound site. This suggests that the TREX2 protein
may prefer to function with both active sites engaged
simultaneously.
DNA strand displacement
Although the TREX exonucleases are very eﬃcient at
hydrolyzing ssDNA substrates, it is likely that at least
some of the biological substrates recognized by these
enzymes are nicked dsDNA or dsDNA ends (1,26).
The TREX1 protein was recently shown to participate in
the SET complex where it functions to degrade DNA
nicked by the NM23-H1 endonuclease. The architecture
of the TREX active sites appears optimized to interact
with ssDNA. It is likely that when the protein interacts
with dsDNA, single-strand displacement is required to
provide a suitable substrate end of about 4nt to properly
bind in the active site for catalysis. Our current structure
of the TREX2–DNA complex has provided us with addi-
tional information about the TREX proteins potential
interactions with dsDNA. Due to the symmetry within
the crystal, the ssDNA molecules interacting with separate
TREX2 monomers are positioned adjacent to one another
in an anti-parallel orientation to form a pseudo-dsDNA
molecule (Figure 4). With the 30-terminus of the substrate
strand anchored in the active site, the 50-end of the ‘com-
plementary’ strand abuts the b1-2 loop. This loop contains
the conserved Pro21 and Leu20 residues that form part of
the active site cleft. The positioning of the proline at the
interface of the nucleotide strands suggests it may act to
unzip and denature the dsDNA and feed the substrate
strand into the active site.
b-Hairpinrole inprotein–protein interaction
While a biological role for the TREX1 enzyme in the cell
has been deﬁned (1,4), the exact function for the TREX2
protein remains unclear. TREX1 is known to participate
Figure 4. DNA strand displacement by TREX2. Stereo ﬁgure showing how the TREX2 protein potentially interacts with dsDNA. Lattice packing
interactions in the crystal created a pseudo-dsDNA that show the 50-end abutted against the b1-2 loop. This loop which forms part of the substrate
binding pocket may play a role in DNA strand displacement to provide ssDNA to the active site from a DNA duplex.
Nucleic Acids Research,2009, Vol.37, No. 7 2415in the SET complex where it directly interacts with the
SET protein and acts to rapidly degrade 30-ends of
nicked DNA during granzyme A-mediated cell death.
TREX1 was shown to act within a complex of proteins
that include the NM23-H1 nuclease, pp32, HMG-2 and
APE1 and to bind directly to the SET protein (1). It is
thought that a polyproline II helix (PPH) motif in the
TREX1 protein mediates the interactions with the SET
complex (9,10). Interestingly, TREX2 was speciﬁcally
shown not to interact in this complex, again suggesting
TREX2 is recruited to a diﬀerent DNA metabolizing
pathway. A superposition of the TREX2 and the
TREX1 dimers shows very high similarity overall in the
two structures (RMSD=1.2A ˚ ,C a atoms using pdbid
1Y97 and 2IOC). The single major diﬀerence between
the two, however, is at the position of the PPH at the
TREX1 dimer interface that is instead a b-hairpin in the
TREX2 structure (Figure 5). The PPH forms a distinct
three-sided, left-handed helix and is ideally situated to
mediate interactions between TREX1 and other proteins
allowing positioning adjacent to the exonuclease active
site. The b-hairpin in TREX2 is in the identical position
as the PPH in TREX1 and protrudes from the surface of
the dimer in a similar fashion; suggesting that it may act
in a similar capacity to mediate protein–protein interac-
tions. This subtle diﬀerence in structure between the two
proteins may provide the selectivity switch that allows
the recruitment of each exonuclease to the appropriate
complex.
In conclusion, the TREX2–DNA complex has revealed
new information about the interaction of this enzyme with
substrate. We have observed a conformational change in
the enzyme active site upon DNA binding along with a
sequential mode of binding that is distinct from that seen
with the TREX1 protein. A structural motif in the active
site has been identiﬁed that may play a role in strand dis-
placement of dsDNA to provide a single-stranded sub-
strate for the enzyme. The unique structural aspects
identiﬁed in the TREX2–DNA complex compared to the
TREX1–DNA complex predict novel biological roles for
these two closely related 30-exonucleases.
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